Advertisement

Colorectal Cancer

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

The cause of colorectal cancer is not understood and appears to involve interactions between inherited susceptibility and environmental factors. Environmental factors play an important role and can increase the risk of colon cancer. The symptoms of colorectal cancer are similar to that of many other bowel disorders, but early colon cancer is asymptomatic. The risk of developing colorectal cancer rises sharply after the age of 40 years. A person under 40 years with positive family history should be investigated. It is appropriate to perform one or all the following in the order to make a firm diagnosis.

Keywords

Colorectal cancer Western diet Familial adenomatosis Polyposis 

References

  1. 1.
    Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registers, 2004. Cancer in Australia 2001. AIHW. Cat No CAN 23. AIHW Canberra.Google Scholar
  2. 2.
    Australian Bureau of Statistics, 2006. Causes of Death, Australia, 2004. cat.no 3303.0. ABS Canberra.Google Scholar
  3. 3.
    Baquet CR, Commiskey P. Colorectal cancer epidemiology in minorities: a review. J Assoc Acad Minor Phys. 1999;10(3):51–8.PubMedGoogle Scholar
  4. 4.
    Sharma S, O’Keefe SJ. Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J. 2007;83(983):583–9 .CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Lieberman D. Screening/early detection model for colorectal cancer. Why screen. Cancer. 1994;74 (7 Suppl):2023–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Cappell MS. From colonic polyps to colon cancer: pathophysiology clinical presentation screening and colonoscopic therapy. Minerva Gastroenterol Dietol. 2007;53(4):351–73.PubMedGoogle Scholar
  7. 7.
    De Leon PM, Percesepe A. Pathogenesis of colorectal cancer Dig Liver Dis. 2000;32(9):807–821CrossRefGoogle Scholar
  8. 8.
    Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel). 2013;(2):676–713.Google Scholar
  9. 9.
    Coppede F. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation. Cancer Lett. 2014;342(2):238–47.CrossRefPubMedGoogle Scholar
  10. 10.
    Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci.2014;60(3):762–772.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Australian Institute of Health and Welfare (AIHW), 2002. Chronic diseases and associated risk factors in Australia, 2001, Canberra AIHW.Google Scholar
  12. 12.
    Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am. 1996;25(4):793–803.CrossRefPubMedGoogle Scholar
  13. 13.
    Tejpar S. Risk stratification for colorectal cancer and implications for screening. Acta Gastroenterol Belg. 2005;68(2):241–2.PubMedGoogle Scholar
  14. 14.
    Burt RW. Screening of patients with a positive family history of colorectal cancer. Gastrointest Endosc Clin. N Am 1997;7(1):65–79.PubMedGoogle Scholar
  15. 15.
    NHMRC Guidelines for the prevention, early detection and management, A guide for general practitioners. ISBN. 1864960914. Cat No. 9925182.,Google Scholar
  16. 16.
    Atkin W. Options for screening for colorectal cancer. Scand J Gastroenterol. Suppl 2003;(237):13–6.CrossRefGoogle Scholar
  17. 17.
    Whitlock EP, Lin J, Liles E, Bell T, Fu R, O’Connor E, et al. Screening for colorectal cancer: An updated systematic review. Agency for Healthcare Research and Quality (US);2008 Oct. Report :08-05-05124-EF-1.Google Scholar
  18. 18.
    Sun L, Wu H, Guan Y. Colonography by CT, MRI, PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. World J Gastroenerol. 2008;14:853–63.CrossRefGoogle Scholar
  19. 19.
    Scholefeld JH, Moss S, Sufi F, Mangham CM. Hardcastle JD, et al. Effect of faecal occult blood screening for mortality from colorectal cancer: results from a randomized controlled trial. Gut. 2002;50:840–4.CrossRefGoogle Scholar
  20. 20.
    Jorgensen OD, Kronborg O, Finger CA. A randomized study of screening for colorectal cancer using Faecal Occult Blood Test: after 13 years and seven biennial screening rounds. Gut. 1002;50(1): 29–32.Google Scholar
  21. 21.
    Quintero E. Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening? Gastroenterol Hepatol. 2009;32(8):565–76.CrossRefPubMedGoogle Scholar
  22. 22.
    Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ, et al. Detection of APC mutations in faecal DNA from patients with colorectal tumours. N Eng J Med. 2002;346:311–20.CrossRefGoogle Scholar
  23. 23.
    Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.CrossRefPubMedGoogle Scholar
  24. 24.
    Kimura K, Nagasaka T, Hosnizima N. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations. J Int Med Res. 2007;35:450–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Deenadayalu VP, Rex DK. Fecal-based DNA assays: a new non-invasive approach to colorectal screening. Cleveland Clin FJ Med. 2004;71:497–503.CrossRefGoogle Scholar
  26. 26.
    Muller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, et al. Methylation changes in faecal DNA: a marker for colorectal screening. Lancet. 2004; 262:1283–5.CrossRefGoogle Scholar
  27. 27.
    Cancer Research UK. Statistics and outlook for bowel cancer. http://www.cancerresearchuk.org/about-cancer/type/bowel-cancer/treatment/statistics… accessed 15 February 2015.
  28. 28.
    Dunn J, Lynch, Rinaldis M, Pakenham K, McPherson L, Owe N, et al. Dimension of quality of life and psychological variables most salient to colorectal patients. Psychooncology. 2006;15(1):20–30.CrossRefPubMedGoogle Scholar
  29. 29.
    Cotrum H, Pereira G. Impact of colorectal cancer on patient and family; implications for care. Eur J Oncol Nurs. 2008;12(3):217–26.CrossRefGoogle Scholar
  30. 30.
    Avery JC, Nishimoto PW. Psychosocial issues in colorectal cancer survivorship: top ten questions may not be asking. J Gastrointestinal Oncol. 2014;5(5):395–400.  https://doi.org/10.3978/j.issn.2078-6891.2014.058.
  31. 31.
    Ceillenchair AO, Costello L, Finn C, Timmons A, Fitzpatrick P, Kapr K, et al. Inter-relationship between economic and emotional consequences of colorectal cancer for patients and their families: a qualitative study. BMC Gastroenterology. 2012;12:62. doi.10.3.3978/.issn.2078-68912014.058.Google Scholar
  32. 32.
    Ceillencair AO, Hanly P, Skally M, O’Neill C, Sharp L. The economic impact of colorectal cancer: What are the costs and where do they fall ? NCIN:Cancer Outcome Conference 2012;14–15June 2012. Hilton, Birmngham. Metropole, Birmingham.Google Scholar
  33. 33.
    Meester RGS, Donbem CA, Zanber AG, Goide SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer. Screening rates in the United States by 2018. Cancer. 2015;121:2281–2285.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ananda SS, McLaughln SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, et al. Initial impact of Australian National Bowel Cancer Screening Program. Med J Aust. 2009;191(7):378–381.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations